Stock Events

Stock Events

Life Stem Genetics 

$0.000100
4
+$0.00+0%Friday 20:00

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0003
52W Low
0.0001
Volume
1,500
Avg. Volume
351
Mkt Cap
24,583.8
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

May 8Expected
Q4 2012
Q1 2013
Q2 2013
Q3 2013
Q4 2013
Q1 2014
-0.01
-0.01
-0
0
Expected EPS
0
Actual EPS
0

Financials

-Profit Margin
Unprofitable
2013
2014
2022
2023
2024
2025
0Revenue
-10,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.36B
CRISPR Therapeutics focuses on gene editing, directly competing in the advanced genetic manipulation and therapy space similar to Life Stem Genetics' focus on stem cell technologies.
Editas Medicine
EDIT
Mkt Cap402.38M
Editas Medicine operates in the genome editing field, making it a direct competitor in the genetic therapy market, similar to Life Stem Genetics' approach to medical treatments.
Intellia Therapeutics
NTLA
Mkt Cap1.72B
Intellia Therapeutics is a leading developer of CRISPR gene editing, competing in the same advanced therapeutic technology sector as Life Stem Genetics.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.07B
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, competing with Life Stem Genetics in the broader biotech and genetic therapy market.
Vertex Pharmaceuticals
VRTX
Mkt Cap127.93B
Vertex Pharmaceuticals is involved in creating transformative medicines for people with serious diseases, indirectly competing with Life Stem Genetics by targeting genetic diseases at their source.
Alnylam Pharmaceuticals
ALNY
Mkt Cap29.4B
Alnylam Pharmaceuticals is a leader in RNAi (RNA interference) therapies, offering a different but competing approach to treating genetic disorders, similar to Life Stem Genetics' focus.
Ionis Pharmaceuticals
IONS
Mkt Cap7.24B
Ionis Pharmaceuticals specializes in RNA-targeted drug discovery and development, providing a competitive alternative to Life Stem Genetics' stem cell and genetic therapies.
uniQure N.V.
QURE
Mkt Cap1.63B
uniQure is focused on developing gene therapies for patients with severe medical needs, directly competing with Life Stem Genetics in the gene therapy space.

About

Life Stem Genetics Inc., an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical supplements, and intravenous nutritional cocktails, in addition to stem cell banking services. The company provides a variety of stem cell treatments addressing degenerative conditions, cancer, and weight management, alongside anti-aging and anti-viral therapies. Also available are Adistem stem cell treatments tailored for orthopedic, neurological, and lung diseases, as well as hyperbaric oxygen therapy. Life Stem Genetics Inc. maintains a strategic collaborative agreement with American CryoStem Corporation. This company was founded in 2012 and operates from its base in Beverly Hills, California.
Show More
CEO
Gloria Simov
Country
United States
ISIN
US53217Y1038

Listings

OTC Link
US
LIFS

0 Comments

Share your thoughts

FAQs

What is Life Stem Genetics stock price today?▼
The current price of LIFS is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Life Stem Genetics stock price performance more closely on the chart.
What is Life Stem Genetics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Life Stem Genetics stocks are traded under the ticker LIFS.
Is Life Stem Genetics stock price growing?▼
LIFS stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Life Stem Genetics has showed a -50% decrease.
What is Life Stem Genetics market cap?▼
Today Life Stem Genetics has the market capitalization of 24,583.8
What were Life Stem Genetics earnings last quarter?▼
LIFS earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Life Stem Genetics revenue for the last year?▼
Life Stem Genetics revenue for the last year amounts to 0 USD.
What is Life Stem Genetics net income for the last year?▼
LIFS net income for the last year is -10,000 USD.
In which sector is Life Stem Genetics located?▼
Life Stem Genetics operates in the Health & Wellness sector.
When did Life Stem Genetics complete a stock split?▼
The last stock split for Life Stem Genetics was on September 20, 2013 with a ratio of 13:1.
Where is Life Stem Genetics headquartered?▼
Life Stem Genetics is headquartered in East Stroudsburg, United States.